首页> 美国卫生研究院文献>PLoS Neglected Tropical Diseases >Disease severity in patients with visceral leishmaniasis is not altered by co-infection with intestinal parasites
【2h】

Disease severity in patients with visceral leishmaniasis is not altered by co-infection with intestinal parasites

机译:内源性利什曼病患者的疾病严重程度与肠道寄生虫并发感染不会改变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Visceral leishmaniasis (VL) is a neglected tropical disease that affects the poorest communities and can cause substantial morbidity and mortality. Visceral leishmaniasis is characterized by the presence of Leishmania parasites in the spleen, liver and bone marrow, hepatosplenomegaly, pancytopenia, prolonged fever, systemic inflammation and low body mass index (BMI). The factors impacting on the severity of VL are poorly characterized. Here we performed a cross-sectional study to assess whether co-infection of VL patients with intestinal parasites influences disease severity, assessed with clinical and haematological data, inflammation, cytokine profiles and BMI. Data from VL patients was similar to VL patients co-infected with intestinal parasites, suggesting that co-infection of VL patients with intestinal parasites does not alter disease severity.
机译:内脏利什曼病(VL)是一种被忽视的热带病,影响到最贫穷的社区,并可能导致大量发病和死亡。内脏利什曼病的特征是脾脏,肝脏和骨髓中存在利什曼原虫,肝脾肿大,全血细胞减少,长期发热,全身性炎症和低体重指数(BMI)。影响VL严重程度的因素表征不充分。在这里,我们进行了一项横断面研究,以评估VL患者合并肠道寄生虫是否会影响疾病严重程度,并通过临床和血液学数据,炎症,细胞因子谱和BMI进行评估。 VL患者的数据与合并感染肠道寄生虫的VL患者相似,这表明VL患者合并肠道寄生虫并不会改变疾病的严重程度。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号